Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.

Dietary adjustments may help control prostate cancer in men undergoing active surveillance

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may help reduce cancer cell growth in

December 15, 2024

Binghamton University develops app to help study and prevent falls in older adults

Researchers at Binghamton University, State University of New York’s Motion Analysis Research Laboratory have developed an app to help study and prevent falls in older

January 16, 2024

Net Health Integrates Tali’s AI-Powered Ambient Scribing

What You Should Know: – Net Health, a provider of specialized healthcare software solutions, has announced a strategic partnership with Tali, an AI assistant and

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.